Company / Operating Income
CASTLE BIOSCIENCES INC Operating Income History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$42.8M
FY2025
5-year range
-$72.9M / $8.7M
FY2021-FY2025
Trend
-593.8%
vs FY2024
Sector context
#118 of 156
Health Care
What the data says
Operating Income changed -594% YoY in FY2025, a notable deviation from the 7-year average annual change of -138%.
Based on SEC 10-K filings.
-$43M in FY2025.
Improved from -$68M to -$43M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 24% in Health CareTop 76% of 156This company -$42.8M Sector average $733.1M
▼
-105.8% below sector average
Key checks
Key Insights
- In FY2025, operating income decreased 593.8% year-over-year.
- Ranks #118 out of 156 companies in the Health Care sector.
- Peak operating income was recorded in FY2024.
- Lowest operating income in the period was in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$42.8M | -593.8% |
| FY2024 | $8.7M | +112.8% |
| FY2023 | -$68.0M | +6.7% |
| FY2022 | -$72.9M | -81.8% |
| FY2021 | -$40.1M | -512.6% |
| FY2020 | -$6.5M | -189.3% |
| FY2019 | $7.3M | +291.0% |
| FY2018 | -$3.8M | - |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026